Twofold vs Vero: a free plan and SOC 2 Type II
Vero is SOC 2 Type II certified, keeps a free plan after the 7-day trial, and fills any fillable PDF. Pro is $89 a month, or $69 billed yearly.
Used by clinicians at Cleveland Clinic, Harvard Medical School, Johns Hopkins School of Medicine, Mass General, Mount Sinai, Stanford Medicine, and UCLA Health.







Twofold vs Vero, at a glance.
| Feature | Vero, try for free | Twofold |
|---|---|---|
| Free plan | Vero, Free plan: yes10 actions a month, no time limit | Twofold, Free plan: no7-day trial, then paid |
| SOC 2 Type II | Vero, SOC 2 Type II: yesCertified | Twofold, SOC 2 Type II: noIn progress |
| HIPAA compliant | Vero, HIPAA compliant: yes | Twofold, HIPAA compliant: yesWith a BAA on every plan |
| PDF forms | Vero, PDF forms: yesFills any fillable PDF | Drafts letters such as FMLA and prior-auth |
| Diagnosis and billing codes | Vero, Diagnosis and billing codes: yesICD-10-CM, CPT and HCPCS | Twofold, Diagnosis and billing codes: yesCPT and ICD codes |
| Live visit audio never stored | Vero, Live visit audio never stored: yes | Deleted after each note, by default |
| iPhone and Android apps | Vero, iPhone and Android apps: yes | Twofold, iPhone and Android apps: yes |
Everything around the visit, in one workspace.
Scribe
The note is done before the patient leaves.
- Record, type, or upload
- Follows your template
- Understands 60+ languages

Shortness of Breath
Today 1:31 PM · SOAP note
Subjective
2-day history of shortness of breath and wheezing, worse in spring
No fever, no sick contacts, denies chest pain
Objective
T: 36.4°C, BP: 120/84 mmHg, HR: 88 bpm, RR: 24/min, O2 sat: 98% RA
Respiratory: Mild expiratory wheezes bilaterally, no crackles
Assessment
Asthma exacerbation
Plan
Care plan documented and reviewed
Referral for pulmonary function tests
Follow-up timing and return precautions documented
Does this patient’s chart change which guideline applies?
It may. Vero compares the chart context with the inclusion criteria and cautions in the current regional guideline. GINA
It separates points supported by comparative evidence from areas that still require clinical judgment. JAMA
- 1.GINAInternational evidence-based guideline
- 2.JAMASystematic review of comparative outcomes
- 3.NAEPPFocused update to clinical guidance
Which sources should I review for this clinical question?
Vero compares current regional guidance, summarizes where sources agree or differ, and keeps citations beside the answer. GINALancet
- -The relevant regional guideline and its publication date GINA
- -Areas of agreement and uncertainty across sources Lancet
- 1.GINAGlobal Strategy for Asthma Management and Prevention
- 2.TLAsthma: Seminar
Laboratory Requisition
Page 1 of 2Patient's name
Miguel Alvarez
Date of birth
Mar 14, 1985
Insurance member ID
XGH 4821 9307
Patient's telephone number
(312) 555-0182
Additional clinical information (e.g. diagnosis)
Type 2 diabetes, 6-month follow-up (E11.9)
Biochemistry
Where Vero wins.
SOC 2 Type II certified
Audited security today. Twofold’s security page says its SOC 2 Type II certification is still in progress.
A free plan that stays
10 actions a month after the 7-day trial, no card needed. Twofold’s free access ends with its 7-day trial.
Fills any fillable PDF
Upload any fillable PDF and Vero fills it from the visit, on every plan. Twofold drafts letters such as FMLA and prior-auth.